P/E ratio for eHealth (EHTH)
P/E ratio as of April 2025 (TTM): -1.66
According to eHealth's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.65714. At the end of 2022 the company had a P/E ratio of -1.10.
P/E ratio history for eHealth from 2006 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -1.10 | -80.33% |
| 2021 | -5.57 | -113.48% |
| 2020 | 41.3 | 19.48% |
| 2019 | 34.6 | -103.6% |
| 2018 | -960 | 7309.73% |
| 2017 | -13.0 | -68.35% |
| 2016 | -41.0 | 10.82% |
| 2015 | -37.0 | 34.98% |
| 2014 | -27.4 | -104.12% |
| 2013 | 664 | 770.06% |
| 2012 | 76.3 | 66.17% |
| 2011 | 45.9 | 146.04% |
| 2010 | 18.7 | -28.41% |
| 2009 | 26.1 | 11.94% |
| 2008 | 23.3 | -1.32% |
| 2007 | 23.6 | 73.65% |
| 2006 | 13.6 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 | 27.5 | -1,759.37% | 🇬🇧 UK |
 | 42.8 | -2,685.19% | 🇺🇸 USA |
 | 58.4 | -3,625.48% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.